Literature DB >> 20971879

Identification of the Mhc region as an asthma susceptibility locus in recombinant congenic mice.

Martijn C Nawijn1, Benoit J A Piavaux, Prescilla V Jeurink, Renée Gras, Marjan A Reinders, Timothy Stearns, Simon Foote, Machteld N Hylkema, Peter C Groot, Ron Korstanje, Antoon J M Van Oosterhout.   

Abstract

Mouse models of allergic asthma are characterized by airway hyperreactivity (AHR), Th2-driven eosinophilic airway inflammation, high allergen-specific IgE (anti-OVA IgE) levels in serum, and airway remodeling. Because asthma susceptibility has a strong genetic component, we aimed to identify new asthma susceptibility genes in the mouse by analyzing the asthma phenotypes of the Leishmania major resistant (lmr) recombinant congenic (RC) strains. The lmr RC strains are derived from C57BL/6 and BALB/c intercrosses and carry congenic loci on chromosome 17 (lmr1) and 9 (lmr2) in both backgrounds. Whereas the lmr2 locus on chromosome 9 contributes to a small background-specific effect on anti-OVA IgE and AHR, the lmr1 locus on chromosome 17 mediates a strong effect on Th2-driven eosinophilic airway inflammation and background-specific effects on anti-OVA IgE and AHR. The lmr1 locus contains almost 600 polymorphic genes. To narrow down this number of candidate genes, we performed genome-wide transcriptional profiling on lung tissue from C.lmr1 RC mice and BALB/c control mice. We identified a small number of differentially expressed genes located within the congenic fragment, including a number of Mhc genes, polymorphic between BALB/c and C57Bl/6. The analysis of asthma phenotypes in the C.B10-H2b RC strain, carrying the C57Bl/6 haplotype of the Mhc locus in a BALB/c genetic background, reveals a strikingly similar asthma phenotype compared with C.lmr1, indicating that the differentially expressed genes located within the C.B10-H2b congenic fragment are the most likely candidate genes to contribute to the reduced asthma phenotypes associated with the C57Bl/6 allele of lmr1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971879      PMCID: PMC3266060          DOI: 10.1165/rcmb.2009-0369OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  48 in total

1.  Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection.

Authors:  L J Roberts; T M Baldwin; T P Speed; E Handman; S J Foote
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

2.  Quantitative trait locus mapping of airway responsiveness to chromosomes 6 and 7 in inbred mice.

Authors:  G T De Sanctis; J B Singer; A Jiao; C N Yandava; Y H Lee; T C Haynes; E S Lander; D R Beier; J M Drazen
Journal:  Am J Physiol       Date:  1999-12

3.  Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21.

Authors:  Dan Nicolae; Nancy J Cox; Lucille A Lester; Daniel Schneider; Zheng Tan; Christine Billstrand; Susan Kuldanek; Joseph Donfack; Paul Kogut; Nina M Patel; Jeffrey Goodenbour; Timothy Howard; Raoul Wolf; Gerard H Koppelman; Steven R White; Rodney Parry; Dirkje S Postma; Deborah Meyers; Eugene R Bleecker; Joan S Hunt; Julian Solway; Carole Ober
Journal:  Am J Hum Genet       Date:  2004-12-20       Impact factor: 11.025

4.  Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family.

Authors:  J J McIntire; S E Umetsu; O Akbari; M Potter; V K Kuchroo; G S Barsh; G J Freeman; D T Umetsu; R H DeKruyff
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

5.  Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits.

Authors:  A Fortin; E Diez; D Rochefort; L Laroche; D Malo; G A Rouleau; P Gros; E Skamene
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

6.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.

Authors:  C L Karp; A Grupe; E Schadt; S L Ewart; M Keane-Moore; P J Cuomo; J Köhl; L Wahl; D Kuperman; S Germer; D Aud; G Peltz; M Wills-Karp
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

7.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice.

Authors:  S L Ewart; D Kuperman; E Schadt; C Tankersley; A Grupe; D M Shubitowski; G Peltz; M Wills-Karp
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

9.  Airway inflammation and remodeling in two mouse models of asthma: comparison of males and females.

Authors:  M J Blacquière; M N Hylkema; D S Postma; M Geerlings; W Timens; B N Melgert
Journal:  Int Arch Allergy Immunol       Date:  2010-04-22       Impact factor: 2.749

10.  Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function.

Authors:  Ian A Yang; Olaf Holz; Rudolf A Jörres; Helgo Magnussen; Sheila J Barton; Santiago Rodríguez; Julie A Cakebread; John W Holloway; Stephen T Holgate
Journal:  Am J Respir Crit Care Med       Date:  2004-10-14       Impact factor: 21.405

View more
  3 in total

1.  Mouse mast cell protease-6 and MHC are involved in the development of experimental asthma.

Authors:  Yue Cui; Joakim S Dahlin; Ricardo Feinstein; Lora G Bankova; Wei Xing; Kichul Shin; Michael F Gurish; Jenny Hallgren
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

2.  Intermediary quantitative traits--an alternative in the identification of disease genes in asthma?

Authors:  M Sargurupremraj; K Pukelsheim; T Hofer; M Wjst
Journal:  Genes Immun       Date:  2013-10-17       Impact factor: 2.676

3.  TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice.

Authors:  Martijn C Nawijn; Alexandre C Motta; Renée Gras; Soheila Shirinbak; Hadi Maazi; Antoon J M van Oosterhout
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.